🇺🇸 FDA
Patent

US 6225070

Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma

expired A61KA61K38/00

Quick answer

US patent 6225070 (Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma) held by The Regents of the University of California expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00